Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
448.20    -0.60 (-0.13%)
Bid:
448.30
Ask:
448.50
Spread: 0.20 (0.045%)
Market Cap: £5.59b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Director/PDMR Shareholding

11 Jun 2024 17:30

RNS Number : 0301S
Melrose Industries PLC
11 June 2024
 

Melrose Industries PLC (the "Company")

Notification of transactions by persons discharging managerial responsibilities

On 11 June 2024, Peter Dilnot, the Company's Chief Executive Officer, and Matthew Gregory, the Company's Chief Financial Officer, were each granted an Award under the Melrose 2024 Performance Share Plan (the "PSP"). Capitalised terms used but not otherwise defined herein shall have the meaning given in the rules of the PSP originally adopted on 2 May 2024, as amended from time to time.

Peter Dilnot's Award was granted over 272,633 Shares and Matthew Gregory's Award was granted over 129,559 Shares. Both of these Awards were granted in the form of an Option with a nil Option Price and will Vest on 11 June 2027 subject to the achievement of performance conditions over the vesting period.

The notification of dealing forms can be found below. The relevant disclosures set out below are provided in accordance with Article 19 of the Market Abuse Regulation (EU) 596/214 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Peter Dilnot

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Melrose Industries PLC

b)

 

LEI

 

 

213800RGNXXZY2M7TR85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

 

Ordinary shares of 160/7 pence each

 

Identification code

ISIN: GB00BNGDN821

b)

 

Nature of the transaction

 

 

Grant of an option with a nil exercise price over ordinary shares of 160/7 pence each under the 2024 Melrose Industries PLC Performance Share Plan

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0

272,633

d)

 

Aggregated information

N/A (single transaction)

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

11 June 2024

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Matthew Gregory

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Melrose Industries PLC

b)

 

LEI

 

 

213800RGNXXZY2M7TR85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 160/7 pence each

 

Identification code

ISIN: GB00BNGDN821

b)

 

Nature of the transaction

 

 

Grant of an option with a nil exercise price over ordinary shares of 160/7 pence each under the 2024 Melrose Industries PLC Performance Share Plan

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0

129,559

 

 

 

 

 

d)

 

Aggregated information

N/A (single transaction)

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

11 June 2024

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLRRFILLIS
Date   Source Headline
21st Jun 20237:00 amRNSDirectorate Change
19th Jun 20237:00 amRNSHolding(s) in Company
16th Jun 20234:45 pmRNSDirectorate Change
16th Jun 20231:30 pmRNSHolding(s) in Company
14th Jun 20236:19 pmRNSDirector/PDMR Shareholding
13th Jun 20234:50 pmRNSHolding(s) in Company
9th Jun 202310:00 amRNSHolding(s) in Company
8th Jun 20231:15 pmRNSResult of AGM
2nd Jun 202310:30 amRNSHolding(s) in Company
18th May 20235:15 pmRNSDirector/PDMR Shareholding
18th May 20234:02 pmRNSDirector/PDMR Shareholding
17th May 20231:00 pmRNSCapital Markets Event & New 2025 Guidance
15th May 20237:00 amRNSHolding(s) in Company
11th May 20235:15 pmRNSHolding(s) in Company
10th May 20237:00 amRNSTrading Update & New Guidance
5th May 20237:00 amRNSHolding(s) in Company
4th May 20237:00 amRNSHolding(s) in Company
27th Apr 202311:05 amRNSHolding(s) in Company
25th Apr 20234:35 pmRNSAnnual Report and Notice of Annual General Meeting
21st Apr 20234:00 pmRNSPost-Offer Undertakings Announcement
20th Apr 202312:20 pmRNSHolding(s) in Company
20th Apr 202311:55 amRNSDirector/PDMR Shareholding
20th Apr 20238:14 amRNSCompletion of the demerger of Dowlais
18th Apr 202311:30 amRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNSDirector Declaration
13th Apr 20235:30 pmRNSMelrose Industries
3rd Apr 20237:00 amRNSHolding(s) in Company
31st Mar 20234:00 pmRNSConfirmation of Post-Offer Undertakings
30th Mar 202311:45 amRNSResults of General Meeting
17th Mar 20235:15 pmRNSDirector Declaration
16th Mar 20232:00 pmRNSSecond Interim Dividend - Payment Date
6th Mar 20234:15 pmRNSHolding(s) in Company
3rd Mar 20234:10 pmRNSPublication of a Prospectus
3rd Mar 20234:00 pmRNSCirc re. Demerger Proposal
2nd Mar 20237:00 amRNSFinal Results
17th Feb 20235:00 pmRNSDirector Declaration
31st Jan 20239:45 amRNSHolding(s) in Company
20th Jan 202312:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Update & Capital Markets Event
9th Jan 20237:00 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSCapital Markets Event
16th Nov 20223:00 pmRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSTrading Statement
4th Nov 20225:30 pmRNSDirector Declaration
31st Oct 20227:00 amRNSHolding(s) in Company
27th Oct 20225:37 pmRNSHolding(s) in Company
26th Oct 20225:00 pmRNSDirector/PDMR Shareholding
21st Oct 20229:45 amRNSHolding(s) in Company
17th Oct 20223:00 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.